Regional action needed to halt antimalarial drug resistance in Africa.
Martinez-Vega R. et al, (2025), Lancet, 405, 7 - 10
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS Med, 21
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
Taylor WRJ. et al, (2023), PLoS Negl Trop Dis, 17